Neoadjuvant immunotherapy improves outlook in high-risk melanoma. Nierengarten MB. Cancer 2023;129:1952.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nierengarten MB. Neoadjuvant immunotherapy improves outlook in high-risk melanoma. Cancer 2023;129:1952.
PMID: 37300812